← Open Payments lookup

JENNIFER EASLEY: Open Payments

NPI 1972827251 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 28 payments from 13 companies in 2025. Trend: 2023 $452 · 2024 $463 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
Novo Nordisk Inc8$195
Lilly USA, LLC3$56
AstraZeneca Pharmaceuticals LP3$48
Abbott Laboratories2$41
Axsome Therapeutics, Inc.2$39
ABBVIE INC.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Otsuka America Pharmaceutical, Inc.1$32
Seqirus USA Inc1$31
Exact Sciences Corporation1$20

Products named: Wegovy, Ozempic, JARDIANCE, Auvelity, CAPLYTA, AIRSUPRA, REXULTI, MOUNJARO.

Industry payments across TX — which companies pay providers there.